Multimodal Prognostic System for Heart Failure: A Multi-Center Study
Developing a Prognostic Warning System for Heart Failure Based on Multimodal Clinical Data: a Multi-center Retrospective Study
1 other identifier
observational
100,000
0 countries
N/A
Brief Summary
This study is a multicenter retrospective research aimed at developing a heart failure prognosis warning system based on multimodal clinical data to improve the diagnosis and treatment of heart failure. This study aims to address the following main questions:
- 1.What are the clinical characteristics and current treatment status of heart failure patients?
- 2.What factors influence the onset of heart failure and the prognosis of patients?
- 3.How can real-world big data be utilized to construct an accurate heart failure prognosis assessment model?
- 4.How can this prognosis assessment model help improve the therapeutic effects and quality of life for heart failure patients?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 14, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 16, 2024
August 1, 2024
4 months
August 14, 2024
August 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
In-hospital mortality or other adverse outcomes, including readmission, in-hospital infection, respiratory failure, liver failure, and renal failure.
The study focuses on evaluating the risk factors and predictors of in-hospital mortality and various adverse outcomes in heart failure patients, encompassing events such as readmission due to exacerbation of the condition, infections acquired during hospital stay, critical impairments in respiratory, liver, and kidney functions that may complicate the clinical course and impact patient prognosis.
Evaluations will be conducted within 30, 60, or 90 days post-admission for heart failure patients to assess the impact of the condition and the effectiveness of treatment.
Eligibility Criteria
The study population for this research consists of adult patients, aged 18 and above, with a discharge diagnosis of heart failure between January 2011 and December 2024, as per the guidelines for the diagnosis and treatment of heart failure . The patients' electronic medical records, which include demographic information, comorbidities, treatment plans, and various clinical indicators, are sourced , ensuring a comprehensive and in-depth analysis of the heart failure patient cohort.
You may qualify if:
- Age Requirement: We plan to include adult patients aged 18 and above to ensure the study covers a broad spectrum of the adult heart failure patient population.
- Diagnostic Criteria: Patients should have a discharge diagnosis of heart failure according to the guidelines for heart failure diagnosis and treatment.
- Time Frame: The discharge time of patients should be between January 2011 and December 2024 to collect and analyze data from the past several years.
- Data Integrity: There is a preference for including medical records with high data integrity, but the specific criteria may be adjusted according to the actual situation of the dataset.
You may not qualify if:
- Diagnostic Inconsistency: Patients with unclear diagnoses or potential for confusion with other diseases may be excluded to ensure the specificity of the study.
- Non-standard Treatment: Patients who have not received treatment according to the established treatment protocol may be excluded to reduce the impact of treatment variability on the study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- student
Study Record Dates
First Submitted
August 14, 2024
First Posted
August 16, 2024
Study Start
August 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
August 16, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
The data analyzed in this study are subject to the following licenses/restrictions: due to ethics committee regulations, the access to the dataset supporting the findings of this study is limited and not public. Requests to access these datasets should be directed to XZ Liu(xiaozhuliu2021@163.com).